gms | German Medical Science

34. Kongress der Deutschsprachigen Gesellschaft für Intraokularlinsen-Implantation, Interventionelle und Refraktive Chirurgie (DGII)

Deutschsprachige Gesellschaft für Intraokularlinsen-Implantation, Interventionelle und Refraktive Chirurgie (DGII)

13.02. - 15.02.2020, Mainz

Artikel

Artikel empfehlen

Incidence of IOL rotation after toric IOL implantation

Meeting Abstract

Suche in Medline nach

  • Katarzyna H. Pawlowicz - Frankfurt a.M.
  • K. Varna-Tigka - Frankfurt a.M.
  • T. Arad - Frankfurt a.M.
  • C. Lwowski - Frankfurt a.M.
  • W. Ahmad - Frankfurt a.M.
  • L. Hinzelmann - Frankfurt a.M.
  • T. Kohnen - Frankfurt a.M.

Deutschsprachige Gesellschaft für Intraokularlinsen-Implantation, Interventionelle und Refraktive Chirurgie. 34. Kongress der Deutschsprachigen Gesellschaft für Intraokularlinsen-Implantation, interventionelle und refraktive Chirurgie. Mainz, 13.-15.02.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. Doc20dgii78

doi: 10.3205/20dgii78, urn:nbn:de:0183-20dgii783

Veröffentlicht: 18. Juni 2020

© 2020 Pawlowicz et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.

Gliederung

Text

Purpose: To evaluate the incidence of IOL rotation in patients with a history of toric IOL Implantation for astigmatism.

Design: Retrospective consecutive case series.

Methods: Case records of patients who underwent surgery to rotate their intraocular lens after implantation of a toric IOL were screened. Pre-operative and post-operative data was taken from the patient files.

Results: 673 eyes were implanted a toric IOL in the last three years. 65 eyes were subsequently rotated because of suboptimal lens axis orientation. Data is currently being analyzed.

Conclusion: In our collective from 2017 until 2019, 55 of 673 eyes were repositioned after toric IOL Implantation to improve their visual acuity.

Financial disclosure:

T. Kohnen: Consultant and Research for Abbott/J&J, Alcon/Novartis, Avedro, Oculentis, Oculus, Presbia, Schwind, Zeiss. Consultant for Allergan, Bausch & Lomb, Dompé, Geuder, Merck, Rayner, Santen, Staar, Thea, Tear Lab, Thieme, Uni-Med Verlag, Med Update, Ziemer. Research for Hoya.